Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen.

Authors

Mikhail Yu Artamonov
Tyler W LeBaron
Felix A Pyatakovich
Inessa A Minenko

Publication/Presentation Date

4-7-2024

Abstract

Stem cell therapy has emerged as a promising avenue for regenerative medicine, offering the potential to treat a wide range of debilitating diseases and injuries. Among the various types of stem cells, mesenchymal stem cells (MSCs) have garnered significant attention due to their unique properties and therapeutic potential. In recent years, researchers have been exploring novel approaches to enhance the effectiveness of MSC-based therapies. One such approach that has gained traction is the priming of MSCs with molecular hydrogen (H

Volume

17

Issue

4

ISSN

1424-8247

Published In/Presented At

Artamonov, M. Y., LeBaron, T. W., Pyatakovich, F. A., & Minenko, I. A. (2024). Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen. Pharmaceuticals (Basel, Switzerland), 17(4), 469. https://doi.org/10.3390/ph17040469

Disciplines

Medicine and Health Sciences

PubMedID

38675429

Department(s)

Department of Medicine

Document Type

Article